Published in J Biol Chem on September 22, 2011
Integrins and integrin-associated proteins in the cardiac myocyte. Circ Res (2014) 1.00
A potential role for integrin signaling in mechanoelectrical feedback. Prog Biophys Mol Biol (2012) 0.84
The functions and applications of RGD in tumor therapy and tissue engineering. Int J Mol Sci (2013) 0.82
Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression. Oncotarget (2016) 0.81
High fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6. Oncotarget (2016) 0.81
SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss. J Bone Miner Res (2014) 0.79
Bone biology-related gingival transcriptome in ageing and periodontitis in non-human primates. J Clin Periodontol (2016) 0.78
CD44 deficiency inhibits unloading-induced cortical bone loss through downregulation of osteoclast activity. Sci Rep (2015) 0.77
SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model. PLoS One (2014) 0.76
5-Azacytidine-induced protein 2 (AZI2) regulates bone mass by fine-tuning osteoclast survival. J Biol Chem (2015) 0.76
Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy. Oncotarget (2016) 0.75
Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol (1997) 11.57
Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science (1996) 3.84
Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev (2008) 3.06
The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol (2002) 3.05
Osteopontin--a possible anchor of osteoclasts to bone. Proc Natl Acad Sci U S A (1990) 2.90
Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res (1998) 2.49
The osteoclast: friend or foe? Annu Rev Pathol (2008) 2.45
Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. J Biol Chem (1993) 2.27
Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner (1993) 2.16
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol (2000) 2.12
Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci U S A (1999) 2.04
A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med (2004) 2.01
Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol Rev (2009) 2.01
The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J Biol Chem (1999) 1.97
Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J Cell Biochem (2007) 1.90
Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci U S A (1992) 1.86
TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts. Cell Metab (2008) 1.79
Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells. Cancer Res (2007) 1.73
Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med (2001) 1.66
Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem (1991) 1.65
Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med (2010) 1.53
The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem (2001) 1.50
The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function. Immunol Rev (2005) 1.33
Regulation of apoptosis in osteoclasts and osteoblastic cells. Biochem Biophys Res Commun (2005) 1.32
Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology (2001) 1.31
Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts. Proc Natl Acad Sci U S A (2005) 1.28
Ultra-rapid activation of TRPV4 ion channels by mechanical forces applied to cell surface beta1 integrins. Integr Biol (Camb) (2010) 1.23
P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts. J Biol Chem (2005) 1.23
Involvement of alpha(v)beta3 integrins in osteoclast function. J Bone Miner Metab (2007) 1.23
Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion. Bone (2002) 1.21
Convergence of alpha(v)beta(3) integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cgamma in prefusion osteoclasts. J Cell Biol (2001) 1.15
The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcif Tissue Int (2002) 1.15
Expression, signaling, and function of P2X7 receptors in bone. Purinergic Signal (2009) 1.13
Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway. Bone (2007) 1.09
Transcriptional regulation of bone and joint remodeling by NFAT. Immunol Rev (2010) 1.06
Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry. Biochemistry (2005) 1.05
Osteoclast receptors and signaling. Arch Biochem Biophys (2008) 1.05
Osteopontin enhances phagocytosis through a novel osteopontin receptor, the alphaXbeta2 integrin. J Immunol (2009) 1.04
Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity. J Immunol (2006) 1.03
Integrin receptor-mediated mobilisation of intranuclear calcium in rat osteoclasts. J Cell Sci (1993) 0.99
Activity-dependent development of P2X7 current and Ca2+ entry in rabbit osteoclasts. J Biol Chem (2001) 0.97
RANK ligand-induced elevation of cytosolic Ca2+ accelerates nuclear translocation of nuclear factor kappa B in osteoclasts. J Biol Chem (2002) 0.97
Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblasts. J Cell Physiol (1998) 0.97
Osteopontin regulates development and function of invariant natural killer T cells. Proc Natl Acad Sci U S A (2008) 0.97
Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase. Exp Cell Res (2009) 0.94
Osteopontin attenuation of dextran sulfate sodium-induced colitis in mice. Lab Invest (2009) 0.93
Molecular mechanism of the life and death of the osteoclast. Ann N Y Acad Sci (2006) 0.92
Lysophosphatidic acid signals through multiple receptors in osteoclasts to elevate cytosolic calcium concentration, evoke retraction, and promote cell survival. J Biol Chem (2010) 0.88
Polyoma virus-induced osteosarcomas in inbred strains of mice: host determinants of metastasis. PLoS Pathog (2010) 0.84
Immediate cell signal by bone-related peptides in human osteoclast-like cells. Am J Physiol (1993) 0.84
Crystallization of calcium oxalates is controlled by molecular hydrophilicity and specific polyanion-crystal interactions. Langmuir (2009) 0.84
Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: integrin-dependent and -independent actions. Exp Cell Res (1995) 0.82
Roles of osteopontin in bone remodeling. Ann N Y Acad Sci (1995) 0.81
Autocrine secretion of osteopontin results in degradation of I kappa B in Bcr-Abl-expressing cells. Br J Haematol (2005) 0.81
Colony stimulating factor-1-induced osteoclast spreading depends on substrate and requires the vitronectin receptor and the c-src proto-oncogene. J Bone Miner Res (1998) 0.80
Temporal and spatial dynamics underlying capacitative calcium entry in human colonic smooth muscle. Am J Physiol Gastrointest Liver Physiol (2007) 0.79
Bone matrix proteins and extracellular acidification: potential co-regulators of osteoclast morphology. J Cell Biochem (2010) 0.77
Regulation of cancer cell migration and bone metastasis by RANKL. Nature (2006) 5.27
Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol Endocrinol (2003) 1.93
Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. J Cell Physiol (2004) 1.76
Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone (2007) 1.45
P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis. J Cell Biol (2008) 1.34
Inhibition of hydroxyapatite formation by osteopontin phosphopeptides. Biochem J (2004) 1.33
Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling. Bone (2003) 1.29
Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts. Proc Natl Acad Sci U S A (2005) 1.28
P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts. J Biol Chem (2005) 1.23
P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid. J Biol Chem (2006) 1.21
Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice. Circulation (2009) 1.18
Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein. J Biol Chem (2002) 1.15
Expression, signaling, and function of P2X7 receptors in bone. Purinergic Signal (2009) 1.13
Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide. J Am Chem Soc (2007) 1.12
Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway. Bone (2007) 1.09
Estimating the sensitivity of mechanosensitive ion channels to membrane strain and tension. Biophys J (2004) 1.08
Bone sialoprotein-collagen interaction promotes hydroxyapatite nucleation. Matrix Biol (2008) 1.05
Spiers Memorial Lecture. Lessons from biomineralization: comparing the growth strategies of mollusc shell prismatic and nacreous layers in Atrina rigida. Faraday Discuss (2007) 1.05
Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry. Biochemistry (2005) 1.05
Up-regulation of endogenous RGS2 mediates cross-desensitization between Gs and Gq signaling in osteoblasts. J Biol Chem (2006) 1.04
Identification of the type I collagen-binding domain of bone sialoprotein and characterization of the mechanism of interaction. J Biol Chem (2005) 1.02
In vivo micro-CT analysis of bone remodeling in a rat calvarial defect model. Phys Med Biol (2009) 1.02
The flexible polyelectrolyte hypothesis of protein-biomineral interaction. Langmuir (2010) 1.01
Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts. J Bone Miner Res (2004) 1.01
Activation of P2X7 receptors causes isoform-specific translocation of protein kinase C in osteoclasts. J Cell Sci (2008) 0.99
Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. J Am Chem Soc (2011) 0.99
RANK ligand-induced elevation of cytosolic Ca2+ accelerates nuclear translocation of nuclear factor kappa B in osteoclasts. J Biol Chem (2002) 0.97
Effects of isoform-selective phosphatidylinositol 3-kinase inhibitors on osteoclasts: actions on cytoskeletal organization, survival, and resorption. J Biol Chem (2013) 0.96
EP1 receptor-mediated migration of the first trimester human extravillous trophoblast: the role of intracellular calcium and calpain. J Clin Endocrinol Metab (2005) 0.95
Endothelin-1 promotes migration and induces elevation of [Ca2+]i and phosphorylation of MAP kinase of a human extravillous trophoblast cell line. Mol Cell Endocrinol (2003) 0.94
Osteopontin attenuation of dextran sulfate sodium-induced colitis in mice. Lab Invest (2009) 0.93
Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells. J Cell Biochem (2009) 0.91
P2 receptor expression, signaling and function in osteoclasts. Front Biosci (Schol Ed) (2011) 0.91
Functional and molecular analysis of L-type calcium channels in human esophagus and lower esophageal sphincter smooth muscle. Am J Physiol Gastrointest Liver Physiol (2005) 0.90
Loss of equilibrative nucleoside transporter 1 in mice leads to progressive ectopic mineralization of spinal tissues resembling diffuse idiopathic skeletal hyperostosis in humans. J Bone Miner Res (2013) 0.90
P2Y nucleotide receptor signaling through MAPK/ERK is regulated by extracellular matrix: involvement of beta3 integrins. J Cell Physiol (2007) 0.90
Roles of electrostatics and conformation in protein-crystal interactions. PLoS One (2010) 0.89
A tracer study with systemically and locally administered dinitrophenylated osteopontin. J Histochem Cytochem (2004) 0.88
Lysophosphatidic acid signals through multiple receptors in osteoclasts to elevate cytosolic calcium concentration, evoke retraction, and promote cell survival. J Biol Chem (2010) 0.88
Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals. Biophys J (2007) 0.88
P2X₇-mediated calcium influx triggers a sustained, PI3K-dependent increase in metabolic acid production by osteoblast-like cells. Am J Physiol Endocrinol Metab (2011) 0.88
Plasticity of KIR channels in human smooth muscle cells from internal thoracic artery. Am J Physiol Heart Circ Physiol (2003) 0.88
Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle. Am J Physiol Lung Cell Mol Physiol (2005) 0.87
Ca2+-activated Cl- channels in corpus cavernosum smooth muscle: a novel mechanism for control of penile erection. J Appl Physiol (1985) (2002) 0.87
Ascorbate uptake in pig coronary artery endothelial cells. Mol Cell Biochem (2005) 0.87
Role of neuronal nitric oxide synthase in lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal mouse cardiomyocytes. Cardiovasc Res (2007) 0.86
Inhibition of Na/K-ATPase promotes myocardial tumor necrosis factor-alpha protein expression and cardiac dysfunction via calcium/mTOR signaling in endotoxemia. Basic Res Cardiol (2012) 0.86
Functional coupling between the Na+/Ca2+ exchanger and nonselective cation channels during histamine stimulation in guinea pig tracheal smooth muscle. Am J Physiol Lung Cell Mol Physiol (2007) 0.86
Loss of P2X7 nucleotide receptor function leads to abnormal fat distribution in mice. Purinergic Signal (2013) 0.86
Phosphorylation of Ser136 is critical for potent bone sialoprotein-mediated nucleation of hydroxyapatite crystals. Biochem J (2010) 0.86
P2 receptor networks regulate signaling duration over a wide dynamic range of ATP concentrations. J Cell Sci (2013) 0.85
Characterization of a voltage-dependent Na(+) current in human esophageal smooth muscle. Am J Physiol Cell Physiol (2002) 0.84
Role of phosphate groups in inhibition of calcium oxalate crystal growth by osteopontin. Cells Tissues Organs (2008) 0.84
Crystallization of calcium oxalates is controlled by molecular hydrophilicity and specific polyanion-crystal interactions. Langmuir (2009) 0.84
Noncatalytic domain of uPA stimulates human extravillous trophoblast migration by using phospholipase C, phosphatidylinositol 3-kinase and mitogen-activated protein kinase. Exp Cell Res (2003) 0.84
Regulation of intracellular Ca2+ release in corpus cavernosum smooth muscle: synergism between nitric oxide and cGMP. Am J Physiol Cell Physiol (2004) 0.84
Coenzyme Q(1) depletes NAD(P)H and impairs recycling of ascorbate in astrocytes. Brain Res (2006) 0.83
One- and three-dimensional growth of hydroxyapatite nanowires during sol-gel-hydrothermal synthesis. ACS Appl Mater Interfaces (2012) 0.83
Effects of Vitaxin, a novel therapeutic in trial for metastatic bone tumors, on osteoclast functions in vitro. J Cell Biochem (2007) 0.83
Cooperation of phosphates and carboxylates controls calcium oxalate crystallization in ultrafiltered urine. Urol Res (2011) 0.83
Acute vibration induces transient expression of anabolic genes in the murine intervertebral disc. Arthritis Rheum (2013) 0.83
Lysophosphatidic acid: a potential mediator of osteoblast-osteoclast signaling in bone. Biochim Biophys Acta (2012) 0.82
Activation of transcription factors by extracellular nucleotides in immune and related cell types. Purinergic Signal (2007) 0.82
Control of surface topography in biomimetic calcium phosphate coatings. Langmuir (2012) 0.82
Transglutaminase-mediated oligomerization promotes osteoblast adhesive properties of osteopontin and bone sialoprotein. Cell Adh Migr (2011) 0.82
The differential regulation of osteoblast and osteoclast activity by surface topography of hydroxyapatite coatings. Biomaterials (2013) 0.81
Osteopontin mediates Citrobacter rodentium-induced colonic epithelial cell hyperplasia and attaching-effacing lesions. Am J Pathol (2010) 0.81
Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy. Calcif Tissue Int (2009) 0.81
Epidermal growth factor stimulates proton efflux from chondrocytic cells. J Cell Physiol (2002) 0.80
In vivo functional analysis of polyglutamic acid domains in recombinant bone sialoprotein. J Histochem Cytochem (2006) 0.80
On the catalysis of calcium oxalate dihydrate formation by osteopontin peptides. Colloids Surf B Biointerfaces (2012) 0.80
Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals. Cells Tissues Organs (2008) 0.80
Label-free mapping of osteopontin adsorption to calcium oxalate monohydrate crystals by tip-enhanced Raman spectroscopy. J Am Chem Soc (2012) 0.80
Bioactive glass/polymer composite materials with mechanical properties matching those of cortical bone. J Biomed Mater Res A (2006) 0.79
Citrate modulates calcium oxalate crystal growth by face-specific interactions. Cells Tissues Organs (2011) 0.79
Rho-ROCK signaling differentially regulates chondrocyte spreading on fibronectin and bone sialoprotein. Am J Physiol Cell Physiol (2008) 0.79
Peptides of Matrix Gla protein inhibit nucleation and growth of hydroxyapatite and calcium oxalate monohydrate crystals. PLoS One (2013) 0.79
Dynamic light scattering study of inhibition of nucleation and growth of hydroxyapatite crystals by osteopontin. PLoS One (2013) 0.79